- Home
- BCBP vs VTYX Comparison
BCBP vs VTYX Comparison
Compare BCBP & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- VTYX
- Stock Information
- Founded
- BCBP 2000
- VTYX 2018
- Country
- BCBP United States
- VTYX United States
- Employees
- BCBP N/A
- VTYX N/A
- Industry
- BCBP Savings Institutions
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- BCBP Finance
- VTYX Health Care
- Exchange
- BCBP Nasdaq
- VTYX Nasdaq
- Market Cap
- BCBP 143.5M
- VTYX 154.9M
- IPO Year
- BCBP N/A
- VTYX 2021
- Fundamental
- Price
- BCBP $8.66
- VTYX $2.38
- Analyst Decision
- BCBP Hold
- VTYX Buy
- Analyst Count
- BCBP 2
- VTYX 2
- Target Price
- BCBP $9.50
- VTYX $9.00
- AVG Volume (30 Days)
- BCBP 51.7K
- VTYX 448.0K
- Earning Date
- BCBP 10-17-2025
- VTYX 11-06-2025
- Dividend Yield
- BCBP 7.41%
- VTYX N/A
- EPS Growth
- BCBP N/A
- VTYX N/A
- EPS
- BCBP 0.19
- VTYX N/A
- Revenue
- BCBP $65,498,000.00
- VTYX N/A
- Revenue This Year
- BCBP $22.81
- VTYX N/A
- Revenue Next Year
- BCBP $8.60
- VTYX N/A
- P/E Ratio
- BCBP $45.22
- VTYX N/A
- Revenue Growth
- BCBP N/A
- VTYX N/A
- 52 Week Low
- BCBP $7.54
- VTYX $0.78
- 52 Week High
- BCBP $14.04
- VTYX $3.39
- Technical
- Relative Strength Index (RSI)
- BCBP 48.39
- VTYX 44.59
- Support Level
- BCBP $8.52
- VTYX $2.26
- Resistance Level
- BCBP $8.89
- VTYX $2.51
- Average True Range (ATR)
- BCBP 0.17
- VTYX 0.14
- MACD
- BCBP -0.03
- VTYX -0.01
- Stochastic Oscillator
- BCBP 28.72
- VTYX 29.90
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.